A detailed history of Ci Private Wealth, LLC transactions in Atai Life Sciences N.V. stock. As of the latest transaction made, Ci Private Wealth, LLC holds 49,085 shares of ATAI stock, worth $79,026. This represents 0.0% of its overall portfolio holdings.

Number of Shares
49,085
Previous 30,500 60.93%
Holding current value
$79,026
Previous $40,000 40.0%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$1.16 - $1.64 $21,558 - $30,479
18,585 Added 60.93%
49,085 $56,000
Q2 2024

Aug 13, 2024

BUY
$1.27 - $2.6 $15,005 - $30,719
11,815 Added 63.23%
30,500 $40,000
Q1 2024

May 09, 2024

SELL
$1.5 - $2.19 $42,000 - $61,320
-28,000 Reduced 59.98%
18,685 $36,000
Q4 2023

Feb 09, 2024

SELL
$1.04 - $1.55 $5,408 - $8,060
-5,200 Reduced 10.02%
46,685 $65,000
Q3 2023

Nov 03, 2023

BUY
$1.27 - $2.28 $27,031 - $48,529
21,285 Added 69.56%
51,885 $66,000
Q2 2023

Aug 10, 2023

SELL
$1.44 - $2.19 $29,376 - $44,676
-20,400 Reduced 40.0%
30,600 $52,000
Q1 2023

May 15, 2023

BUY
$1.17 - $2.7 $42,412 - $97,875
36,250 Added 245.76%
51,000 $92,000
Q4 2022

Feb 15, 2023

BUY
$2.38 - $3.55 $35,105 - $52,362
14,750 New
14,750 $39,000

Others Institutions Holding ATAI

About ATAI Life Sciences N.V.


  • Ticker ATAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 165,875,008
  • Market Cap $267M
  • Description
  • Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...
More about ATAI
Track This Portfolio

Track Ci Private Wealth, LLC Portfolio

Follow Ci Private Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ci Private Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ci Private Wealth, LLC with notifications on news.